0
Hypertension Collection
The most recent journal, In the Clinic, and Summaries for Patients articles
Original Research |  30 August 2016 ONLINE FIRST
Cost-Effectiveness of Sacubitril–Valsartan in Patients With Heart Failure With Reduced Ejection FractionSacubitril–Valsartan in Heart Failure With Reduced Ejection Fraction
Alexander T. Sandhu, MD, MS; Daniel A. Ollendorf, PhD; Richard H. Chapman, PhD; et al.
Ann Intern Med. Published online 30 August 2016 doi:10.7326/M16-0057
Editorials |  30 August 2016 ONLINE FIRST
Sacubitril–Valsartan in Heart Failure: Why Are More Physicians Not Prescribing It?Sacubitril–Valsartan in Heart Failure
Milton Packer, MD; W. Mark Armstrong, MD; Joseph M. Rothstein, MD; et al.
Ann Intern Med. Published online 30 August 2016 doi:10.7326/M16-1932
Ideas and Opinions |  16 August 2016 ONLINE FIRST
Chlorthalidone Versus Hydrochlorothiazide: A New Kind of Veterans Affairs Cooperative StudyChlorthalidone Versus Hydrochlorothiazide
Frank A. Lederle, MD; William C. Cushman, MD; Ryan E. Ferguson, ScD, MPH; et al.
Ann Intern Med. Published online 16 August 2016 doi:10.7326/M16-1208
In the Clinic |  2 December 2014
Hypertension
Matthew R. Weir, MD
Ann Intern Med. 2014;161(11):ITC1. doi:10.7326/0003-4819-161-11-201412020-01006
In the Clinic |  2 December 2008
Hypertension
Debbie L. Cohen, MD; Raymond R. Townsend, MD
Ann Intern Med. 2008;149(11):ITC6-1. doi:10.7326/0003-4819-149-11-200812020-01006
In the Clinic |  6 March 2007
Peripheral Arterial Disease
Jennifer F. Wilson
Ann Intern Med. 2007;146(5):ITC3-1. doi:10.7326/0003-4819-146-5-200703060-01003
ACP Journal Club |  16 August 2016
In adults ≥ 75 years of age with hypertension, intensive vs standard BP-lowering treatment reduced CV events
Paul Shekelle, MD
Ann Intern Med. 2016;165(4):JC14. doi:10.7326/ACPJC-2016-165-4-014
ACP Journal Club |  19 July 2016
Combination candesartan–HCTZ did not reduce major CV events in patients at intermediate CV risk
Charles B. Eaton MD, MS
Ann Intern Med. 2016;165(2):JC7. doi:10.7326/ACPJC-2016-165-2-007
ACP Journal Club |  19 July 2016
Adding candesartan-HCTZ to rosuvastatin increased adverse events but not benefits in patients at intermediate CV risk
Charles B. Eaton MD, MS
Ann Intern Med. 2016;165(2):JC8. doi:10.7326/ACPJC-2016-165-2-008
Summaries for Patients
Summaries for Patients |  17 November 2015 FREE
Screening for High Blood Pressure in Adults: U.S. Preventive Services Task Force Recommendation Statement
Ann Intern Med. 2015;163(10):I-32. doi:10.7326/P15-9036
Summaries for Patients |  2 December 2014 FREE
Aspirin to Prevent Preeclampsia-Related Complications and Death: U.S. Preventive Services Task Force Recommendation Statement
Ann Intern Med. 2014;161(11):I-28. doi:10.7326/P14-9041
Summaries for Patients |  5 November 2013 FREE
Screening for High Blood Pressure in Children and Adolescents: U.S. Preventive Services Task Force Recommendation Statement
Ann Intern Med. 2013;159(9):I-30. doi:10.7326/0003-4819-159-9-201311050-00723
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)